Activated Clotting time (ACT): its diagnostic value in Monitoring low dose Heparin therapy
Article Sidebar
Main Article Content
Abstract
To study diagnostic value of activated clotting time (ACT) in monitoring of low dose heparin therapy. One hundred cases were included in this study. Among them s50 healthy7 noraml subjects (group 1) were taken as control, while 50 were taken among patients of myocardial infarction (group 2) receiving continuous heparin therapy. for both grous of patients the laboratory test ACT and APTT were performed. ACT cannot be substituted for APTT though it can be used as a bedside test to monitor heparin therapy. it is a useful indicator where over heparinziation or under heparinization is suspeected and APTT results are awaited.
Article Details
How to Cite
1.
Zahid S, Tasnim T, Tayyab M. Activated Clotting time (ACT): its diagnostic value in Monitoring low dose Heparin therapy. J Postgrad Med Inst [Internet]. 2011 Oct. 7 [cited 2024 Nov. 21];19(1). Available from: https://jpmi.org.pk/index.php/jpmi/article/view/971
Issue
Section
Original Article
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.